Showing 121 - 140 results of 64,082 for search '(( 5 ht decrease ) OR ( 5 ((wt decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 0.93s Refine Results
  1. 121
  2. 122
  3. 123
  4. 124
  5. 125

    5.HT<sub>1A</sub> binding difference between known cause of death (KCOD) controls and SIDS. by Hannah C. Kinney (10280975)

    Published 2025
    “…When SIDS is compared to all KCOD controls, the HG, NTS, and MAO show a significant mean difference in 5-HT<sub>1A</sub> receptor binding. …”
  6. 126

    Data_Sheet_1_Determining 5HT7R’s Involvement in Modifying the Antihyperalgesic Effects of Electroacupuncture on Rats With Recurrent Migraine.pdf by Lu Liu (171341)

    Published 2021
    “…<p>Electroacupuncture (EA) is widely used in clinical practice to relieve migraine pain. 5-HT<sub>7</sub> receptor (5-HT<sub>7</sub>R) has been reported to play an excitatory role in neuronal systems and regulate hyperalgesic pain and neurogenic inflammation. 5-HT<sub>7</sub>R could influence phosphorylation of protein kinase A (PKA)- or extracellular signal-regulated kinase<sub>1</sub><sub>/</sub><sub>2</sub> (ERK<sub>1</sub><sub>/</sub><sub>2</sub>)-mediated signaling pathways, which mediate sensitization of nociceptive neurons via interacting with cyclic adenosine monophosphate (cAMP). …”
  7. 127
  8. 128

    Data_Sheet_1_5-HT1A Receptor Agonist Promotes Retinal Ganglion Cell Function by Inhibiting OFF-Type Presynaptic Glutamatergic Activity in a Chronic Glaucoma Model.docx by Xujiao Zhou (6661499)

    Published 2019
    “…In addition, the high expression of GS and EAAT2 induced by glaucoma was downregulated by the 5-HT1A receptor agonist 8-OH-DPAT and the 5-HT1A receptor antagonist WAY-100635, respectively. …”
  9. 129

    MMR mutants show decreased mating-type silencing. by Qian Liu (135614)

    Published 2020
    “…MMR deletion strains (<i>pms1Δ</i>, <i>mlh1Δ</i>, and <i>msh2Δ</i>) displayed white with sectors colonies as compared to WT, indicating a loss of gene silencing at the telomere <i>ADE2</i> reporter. …”
  10. 130

    Loss of virulence in the SIN kinase mutants is characterized by decreased fungal burden and host response to infection. by Ana Camila Oliveira Souza (8180958)

    Published 2021
    “…<p><b>A)</b> Analysis of fungal burden by qPCR at day +4 post inoculation. …”
  11. 131

    Preserved NSS at 2 and at 24 hours following ischemia and decreased infarct volume in PAR1 KO mice 24 hours following ischemic stroke. by Efrat Shavit-Stein (3186678)

    Published 2021
    “…(C) Total infarct volume is significantly lower in PAR1 KO mice compared to control (t-test, WT = 6, PAR1 KO = 6). (D) Infarct volume decreases as a function of distance from the ischemic core (slices #5&6). …”
  12. 132
  13. 133

    Image1_The serotonin receptor 5-HT2A modulates lifespan and protein feeding in Drosophila melanogaster.pdf by Allyson S. Munneke (14200148)

    Published 2022
    “…Loss of the 5-HT2A receptor extends lifespan and induces a resistance to changes in dietary protein that are normally detrimental to lifespan. 5-HT2A<sup>−/−</sup> null mutant flies also display decreased protein feeding and protein content in the body. …”
  14. 134

    Image2_The serotonin receptor 5-HT2A modulates lifespan and protein feeding in Drosophila melanogaster.pdf by Allyson S. Munneke (14200148)

    Published 2022
    “…Loss of the 5-HT2A receptor extends lifespan and induces a resistance to changes in dietary protein that are normally detrimental to lifespan. 5-HT2A<sup>−/−</sup> null mutant flies also display decreased protein feeding and protein content in the body. …”
  15. 135

    Image3_The serotonin receptor 5-HT2A modulates lifespan and protein feeding in Drosophila melanogaster.pdf by Allyson S. Munneke (14200148)

    Published 2022
    “…Loss of the 5-HT2A receptor extends lifespan and induces a resistance to changes in dietary protein that are normally detrimental to lifespan. 5-HT2A<sup>−/−</sup> null mutant flies also display decreased protein feeding and protein content in the body. …”
  16. 136
  17. 137
  18. 138
  19. 139
  20. 140

    Image 5_Using sodium glycodeoxycholate to develop a temporary infant-like gut barrier model, in vitro.pdf by Francesca Bietto (21511316)

    Published 2025
    “…</p>Methods<p>This study aimed to develop an in vitro model of the infant gut barrier treating Caco-2/HT29-MTX with 0.5, 0.8, and 1 mM sodium glycodeoxycholate (GDC).…”